LINC01846

Across TCGA pan-cancer cohorts, LINC01846 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC01846’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where LINC01846 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01846 is over-expressed in tumor.

UCEC and HNSC are the cancer types where LINC01846 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01846 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	All	+0.069	.018	2	view →
HNSC	All	III,IV	+0.045	.025	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

LINC01846–UCEC

Open the UCEC breakdown →